BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aviva Systems Biology Launches ChIP-GLAS Service For The Simultaneous Detection Of 20,000 Human Promoters From A Single Sample


8/9/2006 10:15:22 AM

SAN DIEGO, Aug. 8 /PRNewswire/ -- Due to strong customer demand, Aviva Systems Biology (www.avivasysbio.com) announced the launch of a custom service for their novel ChIP-GLAS system. ChIP-GLAS (Chromatin Immunoprecipitation- Guided Ligation And Selection) is a very sensitive method for genome-wide detection of promoters and enhancers that interact with proteins or carry modifications, such as methylation, that affect gene expression. This new service allows researchers to send in their cell/tissue samples or chromatin immunoprecipitated (ChIP) DNA samples, and in return, receive a list of potentially enriched genes.

ChIP-GLAS technology was invented in the laboratory of Dr. Xiangdong Fu, a Professor in the Department of Cellular and Molecular Biology at UC San Diego, and licensed exclusively by Aviva Systems Biology. This technology was also selected for inclusion in the NIH ENCODE (ENCyclopedia Of DNA Elements) development project to identify functional DNA elements within the human genome.

In the ChIP-GLAS procedure, DNA that is bound to transcription factors or hypermethylated is captured, either by a protein-specific antibody or a DNA modification-specific antibody, such as Aviva Systems Biology's methylation-specific anti-5-methylcytosine monoclonal antibody. The captured DNA is then copied, amplified, and finally hybridized to a promoter microarray to reveal the identity of the genes of interest. A unique feature of the ChIP-GLAS system is the GLAS (Guided Ligation And Selection) step. In this step the DNA of interest is specifically selected by annealing to oligonucleotides corresponding to promoters on the microarray. This step decreases the sample complexity, thereby increasing both the sensitivity and the specificity of ChIP-GLAS compared to similar techniques. The annealing step is followed by PCR amplification, labeling, and hybridization to a promoter microarray.

Aviva Systems Biology further developed this technology using its core bioinformatics capabilities to identify and select the basic promoter regions for the microarray oligo designs. 20,000 human and 8000 mouse promoters have been incorporated into the DNA microarrays as the H20K and M8K chips, respectively. Mr. Julian Yuan, CEO of Aviva Systems Biology states, "We are pleased to offer this valuable service to our customers. Together with the release of over 1000 new antibodies for human and mouse transcription factors in 2006, we are excited to help accelerate new scientific discoveries". ChIP-GLAS technology has many important applications that are useful for the understanding of transcription factor/DNA interactions: transcriptional regulation, DNA methylation, mRNA splicing, DNA damage repair, DNA replication, gene deletion and duplication, and many others.

Based in San Diego, California, Aviva Systems Biology is dedicated to the development of reagents for transcription factor research including ChIP-GLAS promoter array systems and antibodies to over 2400 human and mouse putative transcription factors. Aviva Systems Biology also generates antibodies and additional reagents for other important research areas. Learn more about our products and technology at www.transcriptionfactor.com.

Contact Information: Dr. Cynthia Lane 11180 Roselle Street, Suite 300 San Diego, CA 92121 858-552-6979 X106 clane@avivasysbio.com

Aviva Systems Biology

CONTACT: Dr. Cynthia Lane of Aviva Systems Biology, +1-858-552-6979, ext.106, clane@avivasysbio.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES